Tue, 05th Jan 2021 01:20
MEXICO CITY, Jan 4 (Reuters) - Mexico's health regulator
Cofepris has approved the COVID-19 vaccine developed by Oxford
University and AstraZeneca, Foreign Minister Marcelo Ebrard said
on Monday.
"The emergency approval of the AstraZeneca vaccine by
Cofepris is very good news," Ebrard wrote on Twitter. "With
this, production will start soon in Mexico."
(Reporting by Diego Ore)
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of no...
(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's lat...
(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but abo...
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
Astrazeneca (AZN)